SHARAD KUMAR JAIN
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology DENTON, TX NPI 1467494385
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TX BeiGene USA, Inc. All categories
General Payments — all program years on this page
$27,465.61
- Category: General Payments
- Program years: PY2018–2024
- Record count: 135
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,174.86 across 43 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,375.00 | 2 |
| Food and Beverage | $917.51 | 31 |
| Long term medical supply or device loan | $797.60 | 8 |
| Education | $84.75 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $1,237.50 | 1 |
| Acerta Pharma LLC | $1,212.19 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $811.82 | 9 |
| Incyte Corporation | $144.30 | 3 |
| PUMA BIOTECHNOLOGY, INC. | $124.64 | 1 |
| Lilly USA, LLC | $120.45 | 4 |
| Blueprint Medicines Corporation | $111.46 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $57.52 | 2 |
| Celgene Corporation | $53.40 | 3 |
| PFIZER INC. | $40.04 | 2 |
| INTUITIVE SURGICAL, INC. | $37.48 | 1 |
| PharmaEssentia USA Corporation | $34.44 | 1 |
| Janssen Biotech, Inc. | $27.64 | 1 |
| Astellas Pharma US Inc | $25.79 | 1 |
| EISAI INC. | $25.15 | 1 |
| Merck Sharp & Dohme Corporation | $24.64 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $23.38 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.92 | 1 |
| ARRAY BIOPHARMA INC | $15.59 | 1 |
| Daiichi Sankyo Inc. | $14.99 | 1 |
| ABBVIE INC. | $14.52 | 1 |
By program year
Records — PY2024 (43)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.